Plenaxis abarelix injectable suspension: Phase II/III

In a double-blind, dose-ranging Phase II/III in 363 premenopausal women with surgically confirmed endometriosis, the percentage of patients receiving 30 mg, 60 mg or

Read the full 242 word article

How to gain access

Continue reading with a
two-week free trial.